| human | Q5 |
| P496 | ORCID iD | 0000-0002-0765-9460 |
| P69 | educated at | McGill University | Q201492 |
| McGill University Faculty of Medicine and Health Sciences | Q6801306 | ||
| P108 | employer | Perelman School of Medicine at the University of Pennsylvania | Q4120165 |
| P734 | family name | Friedman | Q1451887 |
| Friedman | Q1451887 | ||
| Friedman | Q1451887 | ||
| P101 | field of work | genital herpes | Q7476596 |
| P735 | given name | Harvey | Q19767732 |
| Harvey | Q19767732 | ||
| P106 | occupation | researcher | Q1650915 |
| Q50334880 | 1792Higher Adherence to an Inpatient Treatment Guideline for Community-acquired Pneumonia is Associated with Reduced Mortality in Botswana |
| Q35914367 | A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens |
| Q36845870 | A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine |
| Q46618919 | A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. |
| Q90520696 | A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection |
| Q40210971 | A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model |
| Q75448824 | Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? |
| Q40795835 | Adopting an ethical approach to global health training: the evolution of the Botswana - University of Pennsylvania partnership |
| Q37188380 | An HSV-1 gD mutant virus as an entry-impaired live virus vaccine |
| Q34549656 | An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. |
| Q97894136 | An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection |
| Q37333821 | Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. |
| Q92462186 | Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants |
| Q95417388 | Bacillus Cereus |
| Q34229689 | Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine |
| Q37060288 | Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection |
| Q24646778 | Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E |
| Q34057952 | Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes |
| Q40797568 | Blood and body fluid exposures among US medical students in Botswana |
| Q92356645 | Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in |
| Q37446555 | Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana |
| Q39637899 | Completely assembled virus particles detected by transmission electron microscopy in proximal and mid-axons of neurons infected with herpes simplex virus type 1, herpes simplex virus type 2 and pseudorabies virus |
| Q40799722 | Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy |
| Q37659317 | Effect of a rapid response team on patient outcomes in a community-based teaching hospital |
| Q41685139 | Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial |
| Q40511804 | Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3. |
| Q34545821 | Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. |
| Q34345831 | Herpes simplex virus type 1 evades the effects of antibody and complement in vivo |
| Q39874187 | Herpes simplex virus type 1 glycoprotein E mediates retrograde spread from epithelial cells to neurites |
| Q34092761 | Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins |
| Q39872004 | Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3. |
| Q41873760 | Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding |
| Q81005900 | Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus |
| Q34071917 | Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons |
| Q94456264 | Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection |
| Q59594738 | Higher set theory and mathematical practice |
| Q36372405 | Immune evasion by herpes simplex virus type 1, strategies for virus survival |
| Q36955074 | Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor |
| Q37439603 | Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine |
| Q35275146 | Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa |
| Q45453302 | Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains |
| Q38241377 | Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. |
| Q45459212 | Keratin, a dual role in herpes simplex virus pathogenesis |
| Q45732556 | Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. |
| Q54214534 | Knowledge of HIV Testing Guidelines Among US Internal Medicine Residents: A Decade After the Centers for Disease Control and Prevention's Routine HIV Testing Recommendations. |
| Q40794424 | Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana |
| Q35867958 | Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread |
| Q56532248 | Long Finite Sequences |
| Q42824739 | Medical students in developing countries. |
| Q40560838 | Molecular association of herpes simplex virus type 1 glycoprotein E with membrane protein Us9. |
| Q90196797 | Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes |
| Q64005194 | On Closed Sets of Ordinals |
| Q37506816 | Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey |
| Q40799738 | Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector |
| Q33322531 | Overestimates of survival after HAART: implications for global scale-up efforts |
| Q100517411 | Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine |
| Q37547107 | Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs |
| Q74755803 | Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy |
| Q45065048 | Purpura Annularis Telangiectodes of Majocchi Associated With the Initiation and Rechallenge of Apremilast for Psoriasis Vulgaris |
| Q38281330 | Reducing risk and enhancing education: U.S. medical students on global health electives |
| Q92749370 | Research Mentoring Plan Involving North-South Collaborations |
| Q45256476 | Risk factors for failure to be offered routine HIV testing among adult medical inpatients in Botswana |
| Q46095175 | Robert Austrian. |
| Q39992106 | Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes |
| Q41956848 | Sinus pause in association with Lyme carditis |
| Q33447347 | Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device |
| Q38196195 | Status of prophylactic and therapeutic genital herpes vaccines |
| Q55895926 | Subtle cardinals and linear orderings |
| Q37211860 | Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana |
| Q95722739 | Subversion of innate and adaptive immunity: immune evasion from antibody and complement |
| Q92512520 | Successful application of prime and pull strategy for a therapeutic HSV vaccine |
| Q40798012 | Sustainable International Partnership Building for Academic Medical Centers: Experiences with the Botswana-UPenn Partnership |
| Q34742635 | The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo |
| Q90437526 | Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity |
| Q90764349 | Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana |
| Q47151560 | Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana. |
| Q55406946 | Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs. |
| Q91766368 | Vaccines to prevent genital herpes |
| Q37535379 | Yield of screening for TB and HIV among children failing to thrive in Botswana |
Search more.